tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Telomir Pharmaceuticals Inc

TELO
Add to Watchlist
1.099USD
+0.009+0.87%
Market hours （ET）Quotes delayed by 15 min
75.62MMarket Cap
LossP/E TTM

Telomir Pharmaceuticals Inc

1.099
+0.009+0.87%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

TELO Financials

See Telomir Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Telomir Pharmaceuticals Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.79/-0.07
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.33
41.22%
Analyst Rating
2026/08/16
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Financial Indicators
EPS
-365.42%-0.79
60.65%-0.03
37.02%-0.06
83.19%-0.03
-245.20%-0.17
67.48%-0.07
72.36%-0.10
-250.03%-0.20
6.53%-0.05
-1280.99%-0.23
-2048.94%-0.35
---0.06
---0.05
---0.02
---0.02
---0.01
----
----
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
-843.52%-47.84M
54.54%-990.95K
28.88%-2.06M
81.60%-1.10M
-249.89%-5.07M
65.15%-2.18M
68.93%-2.90M
-250.06%-5.99M
6.54%-1.45M
-1195.12%-6.25M
-1814.86%-9.33M
-632.91%-1.71M
-2112.81%-1.55M
-660.65%-482.94K
---487.10K
---233.50K
---70.06K
---63.49K
Debt to assets ratio
--2.54%
--3.50%
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--2.12%
--25.16%
--8.24%
----
----
----
----
----
Income Statement
Revenue
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
----
52.40%-1.04M
26.53%-2.13M
80.91%-1.15M
-243.84%-5.07M
-14.18%-2.19M
-169.36%-2.91M
-529.48%-6.01M
-3.38%-1.47M
-296.75%-1.92M
-121.44%-1.08M
-308.64%-954.15K
-1935.76%-1.43M
-660.65%-482.94K
---487.10K
---233.50K
---70.06K
---63.49K
Net Profit
-843.52%-47.84M
54.54%-990.95K
28.88%-2.06M
81.60%-1.10M
-249.89%-5.07M
65.15%-2.18M
68.93%-2.90M
-250.06%-5.99M
6.54%-1.45M
-1195.12%-6.25M
-1814.86%-9.33M
-632.91%-1.71M
-2112.81%-1.55M
-660.65%-482.94K
---487.10K
---233.50K
---70.06K
---63.49K
Balance Sheet
Current assets
----
1078.68%5.79M
454.48%7.34M
610.39%7.40M
-60.53%829.61K
-85.98%491.19K
204.21%1.32M
340.94%1.04M
2087.79%2.10M
--3.50M
--435.23K
--236.31K
--96.07K
----
----
----
----
----
Total current liabilities
----
26.83%827.31K
109.70%1.43M
-29.52%422.81K
-34.78%348.39K
34.06%652.29K
-49.01%680.97K
-80.90%599.91K
-73.72%534.15K
--486.55K
--1.34M
--3.14M
--2.03M
----
----
----
----
----
Total assets
546.80%5.37M
1078.68%5.79M
454.48%7.34M
610.39%7.40M
-60.53%829.61K
-85.98%491.19K
-72.26%1.32M
-80.41%1.04M
-64.51%2.10M
--3.50M
--4.77M
--5.32M
--5.92M
----
----
----
----
----
Total liabilities
-4.58%332.42K
26.83%827.31K
109.70%1.43M
-29.52%422.81K
-34.78%348.39K
34.06%652.29K
-49.01%680.97K
-80.90%599.91K
-73.72%534.15K
--486.55K
--1.34M
--3.14M
--2.03M
----
----
----
----
----
Total equity
945.98%5.03M
3180.10%4.96M
819.60%5.91M
1478.77%6.98M
-69.30%481.22K
-105.34%-161.11K
-81.30%643.04K
-79.70%442.07K
-59.70%1.57M
--3.02M
--3.44M
--2.18M
--3.89M
----
----
----
----
----
Cash Flow Statement
Net operating income
-45.36%-1.01M
-105.47%-1.77M
-98.30%-1.20M
7.49%-927.26K
54.27%-696.45K
55.50%-863.13K
44.28%-605.81K
49.96%-1.00M
---1.52M
---1.94M
-325.04%-1.09M
-2331.29%-2.00M
----
----
---255.79K
---82.39K
----
----
Net financing
-40.63%622.11K
--47.35K
11.71%1.16M
16093.18%7.50M
691.14%1.05M
----
-4.48%1.04M
-102.36%-46.91K
--132.44K
--5.21M
332.87%1.09M
2388.86%1.99M
----
----
--250.88K
--80.00K
----
----

FAQs

What are the current assets of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its current assets were 7.34M, with a year-on-year change of 454.48.

What are the total assets of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its total assets of Telomir Pharmaceuticals Inc were 7.34M, with a year-on-year change of 454.48.

What are the total liabilities of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Telomir Pharmaceuticals Inc were 1.43M, with a year-on-year change of 109.70.

What is the total equity of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its total equity of Telomir Pharmaceuticals Inc was 5.91M, with a year-on-year change of 819.60.

What is the net operating income of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Telomir Pharmaceuticals Inc was -10.34M, with a year-on-year change of 11.19.

What is the net financing of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its net financing of Telomir Pharmaceuticals Inc was 9.71M, with a year-on-year change of 53.25.

What is the Earnings Per Share (EPS) of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.33, with a year-on-year change of 41.22.

What is the net income of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its net income was -10.41M, with a year-on-year change of 37.01.

What is the Return on Equity (ROE) of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -317.65, with a year-on-year change of 60.79.

What is the Return on Assets (ROA) of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -240.34, with a year-on-year change of 55.68.

What is the operating profit of Telomir Pharmaceuticals Inc?

According to Telomir Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -10.34M, with a year-on-year change of 11.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy